Tercica announced submission of Marketing Application to the European Agency For Evaluation of Medicinal Products, for the right to sell Increlex in the European Union.
The FDA approved the use of Increlex ™ last August. It is primarily for use in people suffering from Primary Insulin Growth Factor Deficiency (IGFD) or Growth Hormone Gene Deletion.
Increlex ™ is the synthetic version of the hormone IGF, which is released in response to stimulation by Growth Hormone. By giving Increlex™ to children deficient in IGF, the, they should be able to increase in height.
Your Comments
on Can Growth Hormone Stop Aging?
on Biogeneric Human Growth Hormone
on Can Growth Hormone Stop Aging?
on Steroids and Human Growth Hormone Scandal
on High School Athletes To Be Tested
on Steroids and Human Growth Hormone Scandal
on Biogeneric Human Growth Hormone
on Biogeneric Human Growth Hormone
on Biogeneric Human Growth Hormone
on Biogeneric Human Growth Hormone